CITED2 Antikörper (AA 1-275)

Produktnummer ABIN6138641

Produktdetails anti-CITED2 Antikörper

Target: CITED2 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2))

Bindungsspezifität: AA 1-275

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CITED2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Sequenz: MSGLEMADHM MAMNHGRFPD GTNGLHHHPA HRMGMGQFPS PHHHQQQQPQ HAFNALMGEH IHYGAGNMNA TSGIRHAMGP GTVNGGHPPS ALAPAARFNN SQFMGPPVAS QGGSLPASMQ LQKLNNQYFN HHPYPHNHYM PDLHPAAGHQ MNGTNQHFRD CNPKHSGGSS TPGGSGGSST PGGSGSSSGG GAGSSNSGGG SGSGNMPASV AHVPAAMLPP NVIDTDFIDE EVLMSLVIEM GLDRIKELPE LWLGQNEFDF MTDFVCKQQP SRVSC

Kreuzreaktivität: Human, Maus, Ratte

Produktmerkmale: Polyclonal Antibodies

Aufreinigung: Affinity purification

Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-275 of human CITED2 (NP_001161861.2).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB,1:500 - 1:2000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu CITED2

Target: CITED2 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2))

Andere Bezeichnung: CITED2 (CITED2 Produkte)

Synonyme: mrg1 antikoerper, p35srj antikoerper, zgc:103418 antikoerper, CITED2 antikoerper, cite2 antikoerper, ASD8 antikoerper, MRG-1 antikoerper, MRG1 antikoerper, P35SRJ antikoerper, VSD2 antikoerper, AI835299 antikoerper, ER154-like antikoerper, Mrg1 antikoerper, Msg2 antikoerper, Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 antikoerper, Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 antikoerper, Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 antikoerper, Cbp/p300-interacting transactivator 2 antikoerper, Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 L homeolog antikoerper, cited2 antikoerper, CITED2 antikoerper, cite2 antikoerper, Cited2 antikoerper, cited2.L antikoerper

Hintergrund: The protein encoded by this gene inhibits transactivation of HIF1A-induced genes by competing with binding of hypoxia-inducible factor 1-alpha to p300-CH1. Mutations in this gene are a cause of cardiac septal defects. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.,CITED2,ASD8,MRG-1,MRG1,P35SRJ,VSD2,Epigenetics & Nuclear Signaling,Nuclear Receptor Signaling,Cancer,Invasion and Metastasis,Endocrine & Metabolism,Cardiovascular,Hypoxia,Hypoxia-related proteins,Hypoxia-Regulated,CITED2

Molekulargewicht: 23 kDa/28 kDa

Gen-ID: 10370

UniProt: Q99967

Pathways: Tube Formation